The University of Nevada, Reno School of Medicine

Targeting Remission in Psoriasis: Practical Insights on National Psoriasis Foundation Criteria and Biologic Treatment Strategies

MD, MPH

Recognize the clinical parameters that define on-treatment remission in psoriasis based on the National Psoriasis Foundation (NPF) consensus criteria to guide therapeutic goals 

Interpret clinical trial evidence on current biologics to support achieving on-treatment remission in psoriasis

large_psoriasis elbow stock image.jpg

medium_psoriasis elbow stock image.jpg

small_psoriasis elbow stock image.jpg

thumbnail_psoriasis elbow stock image.jpg

psoriasis elbow stock image.jpg

Psoriasis is a chronic, immune-mediated inflammatory disease characterized by dysregulated IL-23/IL-17 axis signaling and keratinocyte hyperproliferation, resulting in well-demarcated erythematous plaques with silvery scale. Beyond cutaneous involvement, psoriasis has been linked to systemic inflammation contributing to increased risk of cardiometabolic and other inflammatory comorbidities.

This hub gathers the evidence, expert perspective, and practical insight shaping how psoriasis is understood and treated today, connecting advances in targeted therapy with the everyday decisions required to manage chronic inflammation and systemic risk.

WCH26: Targeting Remission in Psoriasis: Practical Insights on National Psoriasis Foundation Criteria and Biologic Treatment Strategies

About

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures